Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
MRI measurements predicted response to neoadjuvant chemotherapy and survival
July 21st, 2005
Magnetic resonance imaging (MRI) measurements of breast tumor volume predicted response to neoadjuvant chemotherapy and recurrence-free survival. "The purpose of this study was to assess the value of MRI measurements of breast tumor size for predicting recurrence-free survival (RFS) in patients undergoing neoadjuvant (preoperative) chemotherapy and to compare the predictive value of MRI with that of established prognostic indicators," scientists in the United States reported. "The study included 62 patients undergoing neoadjuvant chemotherapy. The longest diameter and volume of each tumor were measured on MRI before and after 1 and 4 cycles of...
Source: Women's Health Weekly (2005-07-21)
|
